PEDEVCO CORP. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by PEDEVCO CORP. on January 23, 2023. The filing discloses executive compensation actions taken in connection with the Company's 2022 annual compensation review, approved by the Board of Directors following a recommendation from the Compensation Committee.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. The financial data presented is limited to specific compensation awards and cash bonuses.
- Restricted Stock Issued: 1,250,000 shares of common stock.
- Stock Options Granted: 540,000 options with an exercise price of $1.09 per share.
- Cash Bonuses Approved: $237,000 total for three executive officers.
Material Changes and Compensation Details
The Company granted equity and cash compensation to key officers and employees under the 2021 Equity Incentive Plan. All equity awards are subject to a three-year vesting schedule contingent on continued service.
Restricted Stock Allocation
- Dr. Simon G. Kukes (CEO): 400,000 shares.
- Mr. J. Douglas Schick (President): 350,000 shares.
- Mr. Clark R. Moore (EVP, General Counsel, Secretary): 300,000 shares.
- Mr. Paul Pinkston (Chief Accounting Officer): 200,000 shares.
Stock Option Allocation
- Recipients: Certain non-executive employees.
- Quantity: 540,000 shares.
- Terms: Five-year options with an exercise price of $1.09 per share.
Cash Bonus Allocation
- Mr. J. Douglas Schick: $102,000.
- Mr. Clark R. Moore: $98,000.
- Mr. Paul Pinkston: $37,000.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, outlook, or discussion of risks and contingencies. The primary contingency noted is that all equity awards are subject to the recipient's continued service to the Company on the specified vesting dates.
Investor Verification Checklist
- Verify the total number of shares outstanding and the dilution impact of the 1,250,000 new restricted shares and 540,000 options.
- Review the full terms of the Restricted Shares Grant Agreement (Exhibit 10.2) and Stock Option Grant Agreement (Exhibit 10.3) for specific forfeiture conditions.
- Confirm the Company's ability to fund the $237,000 in approved cash bonuses.
- Check the current market price of PED stock relative to the $1.09 option exercise price to assess the intrinsic value of the grants.